Every Spin-Off
Ennature Bio Pharma
AnnouncedINMakes plant-based nutraceutical and pharmaceutical ingredients, such as turmeric, ginger and marigold extracts, and bio-polymers in India, carved out of India Glycols.
India Glycols' bio-pharma and bio-polymers business, separated in a three-way split of the company.
- Status
- Announced
- Expected
- Awaiting record date
- Parent
- India Glycols (INDIAGLYCO IN)
- Spin-off ticker
- To be announced
- Listing
- NSE and BSE
- Market
- India
- Sector
- Health care
Terms
1 Ennature Bio Pharma share for every 3 India Glycols shares; NCLT Allahabad sanctioned the scheme on 17 Jul 2026 (certified order 20 Aug 2026); appointed date 1 Apr 2026; effective and record dates to be set; listing on NSE and BSE planned.
Key dates
- NCLT sanction
- Certified order received
- Record date
- Listing
Source documents
- Press releaseNot yet published
- PresentationNot yet published
- Prospectus / demerger documentNot yet public
- Sourcemultibagg.ai
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email